Minervax

0 followers


Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Per Fischer

Collapse
Bjørn Kantsø
CTO, Head of CMC
Ebbe Englev
Vice President Clinical Development
Karina Nymark
Vice President Clinical Operations
Msc Sten Verland
Chairman Audit Committee
Tina Biehl
Vice President Bioanalysis & Analytical Quality
Anders Fink V.
Interim Chief Financial Officer, Consulting Role